Radiopharm Theranostics Ltd (RADX) Form 6-K — Aug 27, 2026
Radiopharm Theranostics Limited filed a Form 6-K on August 27, 2026 furnishing four ASX Change of Director's Interest Notices covering its directors. The notices show that listed options held by directors Riccardo Canevari, Paul Hopper, Ian Turner and Hester Larkin expired unexercised on August 24, 2026, removing roughly 31.5 million options in aggregate, including 27.5 million held by Hopper and 1.875 million each for Canevari and Turner. No shares were sold and no cash consideration changed hands; the changes are purely administrative option expiries.
Key figures
- Option expiry date
- 2026-08-24
- Hopper options after
- 35159518
- Larkin options after
- 9900002
- Turner options after
- 22027348
- Canevari options after
- 183412299
- Hopper total shares after
- 147721428
- Larkin total shares after
- 644247
- Turner total shares after
- 9985292
- Canevari total shares after
- 22679986
- Hopper listed options disposed
- 27500000
- Larkin listed options disposed
- 275000
- Turner listed options disposed
- 1875000
- Canevari listed options disposed
- 1875000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.